PELORIS RAPID TISSUE PROCESSOR
Report
- Report Number
- 1423337-2016-00032
- Event Type
- Injury
- Date Received
- December 22, 2016
- Date of Event
- December 13, 2016
- Report Date
- December 13, 2016
- Manufacturer
- LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
- Product Code
- IEO
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- VA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT BIOPSY SAMPLES FROM A TISSUE PROCESSING RUN WERE UNDER-PROCESSED. ON 13 DECEMBER 2016, LEICA BIOSYSTEMS RECEIVED INFORMATION THAT RE-BIOPSY OF TWO (2) MALE PATIENTS WILL BE REQUIRED. IT WAS ALSO DOCUMENTED THAT THE INSTITUTION WAS NOT PREPARED TO PROVIDE ANY FURTHER PATIENT DETAILS. INVESTIGATION OF THIS COMPLAINT BY LEICA BIOSYSTEMS IS IN PROGRESS AND IF ADDITIONAL INFORMATION BECOMES AVAILABLE A FOLLOW UP REPORT WILL BE SUBMITTED. REFER TO IMPORTER REPORT NUMBERS 1423337-2016-00032 AND 1423337-2016-00033 FOR ALL PATIENTS INVOLVED.
FOLLOWING THE LEICA BIOSYSTEMS MANUFACTURER'S INVESTIGATION OF THIS COMPLAINT, IT WAS FOUND THAT THE INSTRUMENT OPERATED WITHIN SPECIFICATION. THE ROOT CAUSE OF THE SUB-OPTIMAL TISSUE PROCESSING REPORTED WAS A USE ERROR. SPECIFICALLY, A USER FAILED TO COMPLETE MANUAL REPLACEMENT OF A REAGENT IN ACCORDANCE WITH THE MANUFACTURER INSTRUCTIONS DETAILED IN THE LEICA PELORIS/PELORIS LL USER MANUAL, WHICH CONTAINS THE FOLLOWING SPECIFIC WARNING: "ALWAYS CHANGE REAGENTS WHEN PROMPTED. ALWAYS UPDATE STATION DETAILS CORRECTLY - NEVER UPDATE THE DETAILS WITHOUT REPLACING THE REAGENT. FAILURE TO FOLLOW THESE DIRECTIVES CAN LEAD TO TISSUE DAMAGE OR LOSS." SEE MANUFACTURER FOLLOW UP REPORTS 8020030-2016-00090 AND 8020030-2016-00091 FOR MORE SPECIFIC INFORMATION REGARDING THE INVESTIGATION OF THIS COMPLAINT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 848196 | PELORIS RAPID TISSUE PROCESSOR | AUTOMATED TISSUE PROCESSOR | IEO | LEICA BIOSYSTEMS MELBOURNE PTY. LTD. | PELORIS |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |